Home Cart Sign in  
Chemical Structure| 79307-93-0 Chemical Structure| 79307-93-0

Structure of Azelastine HCl
CAS No.: 79307-93-0

Chemical Structure| 79307-93-0

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Azelastine HCl is a selective antagonist of histamine receptor used in the treatment of rhinitis.

Synonyms: Azelastine (hydrochloride); Azelastine hydrochloride; Azeptin

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Azelastine HCl

CAS No. :79307-93-0
Formula : C22H25Cl2N3O
M.W : 418.36
SMILES Code : O=C1N(C2CCN(C)CCC2)N=C(CC3=CC=C(Cl)C=C3)C4=C1C=CC=C4.[H]Cl
Synonyms :
Azelastine (hydrochloride); Azelastine hydrochloride; Azeptin
MDL No. :MFCD00242783
InChI Key :YEJAJYAHJQIWNU-UHFFFAOYSA-N
Pubchem ID :54360

Safety of Azelastine HCl

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of Azelastine HCl

GPCR

Isoform Comparison

Biological Activity

Target
  • Histamine receptor

In Vitro:

Cell Line
Concentration Treated Time Description References
HEp-2 cells 0.024–50 µM 24 hours Test the antiviral activity of Azelastine-HCl against RSV, EC50 of 1.038 µM Viruses. 2023 Nov 23;15(12):2300.
MRC-5 cells 2–12 µM 72 hours Test the antiviral activity of Azelastine-HCl against HCoV-229E, EC50 of 3.4 µM Viruses. 2023 Nov 23;15(12):2300.
Vero-TMPRSS2/ACE2 cells 0.05–12.5 µM 48 hours Test the antiviral activity of Azelastine-HCl against SARS-CoV-2 omicron variant, EC50 of 2.8 µM Viruses. 2023 Nov 23;15(12):2300.
Reconstituted human nasal tissue 0.02% (523.5 µM) 20 minutes, repeated every 24 hours for 3 days Evaluate the antiviral effect of Azelastine nasal spray against SARS-CoV-2 infection, significantly reducing viral particle numbers Front Pharmacol. 2022 Jun 30;13:861295.
Vero-TMPRSS2/ACE2 cells 0.4–12.5 µM 48 hours Evaluate the antiviral effect of Azelastine against SARS-CoV-2 variants, with EC50 values ranging from 2.8–6.5 µM Front Pharmacol. 2022 Jun 30;13:861295.
Vero E6 cells 0.4–12.5 µM 48 hours Evaluate the antiviral effect of Azelastine against SARS-CoV-2 infection, with EC50 values of approximately 2.2 and 6.5 µM Front Pharmacol. 2022 Jun 30;13:861295.

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
BALB/c nude mice HT29 cell xenograft model Oral 10 mg/kg or 20 mg/kg Every two days To evaluate the inhibitory effect of Azelastine on HT29 cell xenograft tumor growth, results showed that Azelastine significantly inhibited tumor growth. Theranostics. 2021 Jan 1;11(4):1828-1844

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.39mL

0.48mL

0.24mL

11.95mL

2.39mL

1.20mL

23.90mL

4.78mL

2.39mL

References

 

Historical Records

Categories